about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsNew directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityMonoclonal antibody therapy and renal transplantation: focus on adverse effectsPatient involvement in selection of immunosuppressive regimen following transplantationBiologics in organ transplantationCurrent state of renal transplant immunosuppression: Present and futureSelection of induction therapy in kidney transplantationPolyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejectionImmunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.Is it safe to withdraw steroids within seven days of renal transplantation?Immunosuppressive Medications.A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.Association of antibody induction immunosuppression with cancer after kidney transplantation.Novel and emerging targeted-based cancer therapy agents and methods.Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction.Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid MaintenanceTolerogenic therapies in transplantation.Outcomes Associated with Steroid Avoidance and Alemtuzumab among Kidney Transplant RecipientsArtemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trialEnhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.Alemtuzumab induction in pediatric kidney transplantation.HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles.Alemtuzumab as compared to alternative contemporary induction regimens.Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolA randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab.Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.Acute transplant glomerulopathy with monocyte rich infiltrate.Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility.Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol.Emerging drugs for the treatment of transplant rejection.Induction therapy in renal transplant recipients: how convincing is the current evidence?Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation.The role of Thymoglobulin induction in kidney transplantation: an update.Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician.Induction immunosuppression in liver transplantation: a review.
P2860
Q26774993-A2A9BB19-857B-4FC2-9B0A-C9B25849A673Q26823090-1665EDCD-4409-48DA-8281-A79425788127Q26826880-903155A6-6091-45EC-964D-5FB335CD2DA6Q26829069-C89E8B3C-BC05-4403-BF0D-35C01AA14C4DQ26829578-BA3B0A35-6E9D-4022-861B-58B36D3255C9Q26829789-AE5F9C4B-A612-45A0-B8E0-1560E7F59E65Q26864234-64741640-67A3-4418-981B-12FB9BA4DA30Q30239091-73CE1268-8A2A-44D8-8E06-3710FA08A983Q30389408-F1A97560-FA0B-4876-820C-FC0E8B0246ADQ34027642-5D297D12-E782-4D48-8BB8-548314D23970Q34448543-7B775AAA-B142-4DDE-BFDE-8CDB1D04E920Q34484801-08A1DA74-F96D-4439-BC01-EBF7D591DE4FQ34796915-9EDA9ED7-CAD0-4244-B2D3-66399A9D0A0AQ34841849-319C24A5-C3B0-4CEF-8907-C4075C33FA6CQ35344810-6BC3E9AF-E90A-4FEA-A71D-012AF870022AQ35513074-04C85D4D-F6A2-4864-AFEA-E1479B638E75Q35558057-2B29F3E5-9B7B-4B9E-AEA0-CB2C62E1F83BQ35611179-DD2C2770-FEF8-4C74-A4C5-04DD7A633B3FQ35682221-F50B773A-9B40-4EE9-8D0D-F13FFC6736F8Q36102133-7E89EB10-E769-4D87-B7BF-488C7EECBA90Q36250338-6EECF8D8-D3E9-42FA-827A-63BE4CCA48B7Q36368036-D5D13DEB-53BB-494C-A5ED-236CA2770B3AQ36575860-1A8C015D-7AD7-4E7C-A781-08449F442D72Q36818003-B4779EC5-7572-41F4-8E23-6E7845BBF296Q36818017-67A6887B-1189-47BE-9654-36FF73D03D77Q36880514-C2612F3C-DC97-434B-9CE8-6ADF692527B5Q36908763-CCE95D95-077E-4FA2-909A-ED181FE153C2Q37282011-61F35624-F3B6-468D-B3C6-57332692330BQ37346593-7FFBEC85-3029-4ED5-B99C-BAD688EDC7C5Q37387510-C4AEC669-68E8-4B9D-B159-6219BA94509AQ37522631-5B86099A-5286-4B4F-AC73-911E4BF523ABQ37652611-531CDBBC-B5C9-4C9B-909F-9AA1F7618AB3Q37662995-F0B17CA6-0414-48C0-89E8-45C923BCB40DQ37960177-D25832C2-FB62-4392-8331-1A1DA6225F18Q37996078-7775A9EE-5969-4847-BCDE-75C8B7813505Q38009874-046E765F-6C57-4F0D-9468-48112119F099Q38023873-1B03E7F3-288E-4B1C-8868-3ED0512CCF7DQ38051718-FCD1B508-5D40-4C3F-B174-FAA9DB908704Q38057787-C1F2186A-7B3A-4D70-AF2F-FECF06DCF9C5Q38104751-2C3285F2-5332-4221-BF40-4EB2B14C92D7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Alemtuzumab induction in renal transplantation.
@ast
Alemtuzumab induction in renal transplantation.
@en
Alemtuzumab induction in renal transplantation.
@nl
type
label
Alemtuzumab induction in renal transplantation.
@ast
Alemtuzumab induction in renal transplantation.
@en
Alemtuzumab induction in renal transplantation.
@nl
prefLabel
Alemtuzumab induction in renal transplantation.
@ast
Alemtuzumab induction in renal transplantation.
@en
Alemtuzumab induction in renal transplantation.
@nl
P2093
P356
P1476
Alemtuzumab induction in renal transplantation.
@en
P2093
Dixon B Kaufman
E Steve Woodle
INTAC Study Group
John Holman
M Roy First
Michael J Hanaway
Richard Croy
Shamkant Mulgaonkar
V Ram Peddi
P304
P356
10.1056/NEJMOA1009546
P407
P577
2011-05-01T00:00:00Z